The Scientist - Home

A pill is shown on a blue technical background. One half of the pill has a DNA helix on it, and the other half has a depiction of a computer chip, representing the role of artificial intelligence in drug development.
| 3 min read
2026 will be the year that artificial intelligence accelerates multiple aspects of the drug discovery and development pipeline, industry leaders predict.

Latest

Colorful lines and horizontal bars on a dark background as a representative illustration of genomic sequences

Gene Regulators, Not Genes, Underlie Hibernators’ Superpowers

Leafcutter ants carry leaves across a small branch.

Neuropeptides Control Labor Division in Leafcutter Ants

A digital drawing of human leg bones against a blue background.

Obesity Impairs Bone Health in Growing Children

3D illustration of pink cancer cells on a blue background.

Respiratory Viruses Wake Up Dormant Cancer Cells

Image of cows grazing in a field with a blue sky above them.

Inside a Cow's Stomach: The Microbial Magic Behind Milk

Horseshoe crabs sit in the surf on the beach.

Horseshoe Crabs Break Free from Biomedical Testing

Image of the US map with various shades from white to dark red, the darker color indicates more money lost.

SCIMaP Visualizes the True Cost of Science Funding Cuts

Magnifying glass on a stack of documents.

Retraction of Controversial Arsenic-Life Paper Stirs Debate Among Scientists

A young, sick woman sitting on a sofa, blowing her nose with a tissue.

Anticipation of Infection, Even in Virtual Reality, Triggers Immune Responses

Touch with virtual reality. The point of contact of the human hand with the projection on a blue background.

Smart Biology on a Budget: Why Researchers Should Leverage AI to Rethink Experimental Design

3D illustration of a lymphocyte binding to proteins.

BATMAN Signals T Cell Receptor Crossreactivity

Three-dimensional rendering of minibinder molecules, represented as a red and light blue globular protein, as a soluble binder and expressed on the surface of a blue, spherical T cell, interacting with an orange-red, spiky, and vascular cancer cell.

An AI-Generated Protein Helps T Cells Kill Cancer

February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies